U.S. medical devices company Boston Scientific said it agreed to buy British health-care firm BTG for $4.24 billion, bolstering its presence in the growing field of interventional medicine.
from WSJ.com: US Business https://ift.tt/2QY3HFM
via IFTTT
No comments:
Post a Comment